|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | |
| A61K 9/20 | |||
| A61K 39/00 | |||
| A61K 39/12 | |||
| A61K 48/00 | |||
| A61K 9/28 |
| (11) | Number of the document | 3307239 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16808196.6 |
| Date of filing the European patent application | 2016-06-08 | |
| (97) | Date of publication of the European application | 2018-04-18 |
| (45) | Date of publication and mention of the grant of the patent | 2020-09-16 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/036461 |
| Date | 2016-06-08 |
| (87) | Number | WO 2016/200951 |
| Date | 2016-12-15 |
| (30) | Number | Date | Country code |
| 201562175081 P | 2015-06-12 | US |
| (72) |
TRAGER, George, US
TUCKER, Sean, US
KIM, Leesun, US
SCALLAN, Ciaran, US
|
| (73) |
Vaxart, Inc.,
385 Oyster Point Boulevard, Suite 9A, South San Francisco, CA 94080,
US
|
| (54) | FORMULATIONS FOR SMALL INTESTINAL DELIVERY OF RSV AND NOROVIRUS ANTIGENS |
| FORMULATIONS FOR SMALL INTESTINAL DELIVERY OF RSV AND NOROVIRUS ANTIGENS |